Publications by the researcher in collaboration with Almudena Fernández Briera (12)

2024

  1. High-Throughput Mass Spectrometry Analysis of N-Glycans and Protein Markers after FUT8 Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model

    Journal of Proteome Research, Vol. 23, Núm. 4, pp. 1379-1398

2023

  1. Core Fucosylation Mediated by the FucT-8 Enzyme Affects TRAIL-Induced Apoptosis and Sensitivity to Chemotherapy in Human SW480 and SW620 Colorectal Cancer Cells

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

2022

  1. Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

2013

  1. FX enzyme and GDP-L-Fuc transporter expression in colorectal cancer

    Histopathology, Vol. 63, Núm. 2, pp. 174-186

2011

  1. Disease-free survival of colorectal cancer patients in relation to CDw75 antigen expression

    Pathobiology, Vol. 78, Núm. 4, pp. 201-209

  2. Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer

    BMC Cancer, Vol. 11

  3. α(1,6)Fucosyltransferase expression is an independent prognostic factor for disease-free survival in colorectal carcinoma

    Human Pathology, Vol. 42, Núm. 11, pp. 1740-1750

2010

  1. α(1,2)fucosylation in human colorectal carcinoma

    Oncology Letters, Vol. 1, Núm. 2, pp. 361-366

2008

  1. Expression and enzyme activity of α(1,6)fucosyltransferase in human colorectal cancer

    International Journal of Cancer, Vol. 123, Núm. 3, pp. 641-646

  2. Expression and enzyme activity of α(1,6)fucosyltransferase in human colorectal cancer (International Journal of Cancer (2008) 123, (641-646))

    International Journal of Cancer

  3. Expression of alpha(1,6)fucosyltransferase in the early tumorigenesis of human colorectal cancer

    EJC SUPPLEMENTS

2007

  1. Alpha(1,6)fucosyltransferase lmmunohistochemical expression and the survival of patients with colorectal cancer

    EJC SUPPLEMENTS